Immunologically augmented cancer treatment using modern radiotherapy.

Radiation oncology has recently seen tremendous technical advances, resulting in increasing cancer cures. However, malignant neoplasias are systemic diseases and may be lethal even with an excellent tumor local control. Immune therapy has grown to a mature approach in oncology, delivering results impossible only a few years ago. Treatment-limiting mechanisms such as the immune suppressive tumor microenvironment are now to a large extent deciphered, allowing for pharmacological intervention. Interestingly, radiation-based treatment effects have been shown to depend to a large degree on the immune system. Applying the recent advances in radiation therapy in conjunction with immune therapy can be a turning point towards the long-standing aim of curing cancer. Only a detailed understanding of the molecular mechanisms can guide the implementation of combined therapy modalities.

[1]  Colin G Orton,et al.  The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. , 2009, Medical physics.

[2]  Kohei Miyazono,et al.  TGFβ signalling: a complex web in cancer progression , 2010, Nature Reviews Cancer.

[3]  T. Quinn,et al.  Melanoma therapy via peptide-targeted {alpha}-radiation. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  M. Karin,et al.  Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. , 2010, Cytokine & growth factor reviews.

[5]  D. Hallahan,et al.  Radiation induces an antitumour immune response to mouse melanoma , 2009, International journal of radiation biology.

[6]  C. Drake Prostate cancer as a model for tumour immunotherapy , 2010, Nature Reviews Immunology.

[7]  T. Teshima,et al.  Particle irradiation suppresses metastatic potential of cancer cells. , 2005, Cancer research.

[8]  Laurence Zitvogel,et al.  Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy , 2007, Nature Medicine.

[9]  R. Schreiber,et al.  Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.

[10]  Young-Soo Hong,et al.  Geldanamycin inhibits TGF-beta signaling through induction of Hsp70. , 2010, Archives of biochemistry and biophysics.

[11]  R. Figlin,et al.  Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells. , 2009, Cancer research.

[12]  D. Gabrilovich,et al.  Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. , 2011, Trends in immunology.

[13]  S. Ghosh,et al.  NF-κB and the immune response , 2006, Oncogene.

[14]  Jiayuh Lin,et al.  The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines , 2011, BMC Cancer.

[15]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[16]  N. Kawashima,et al.  Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody , 2009, Clinical Cancer Research.

[17]  B. Hann,et al.  TGFβ1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo , 2011, Clinical Cancer Research.

[18]  W. Zimmermann,et al.  Combination immunotherapy and active-specific tumor cell vaccination augments anti-cancer immunity in a mouse model of gastric cancer , 2011, Journal of Translational Medicine.

[19]  P. Okunieff,et al.  The biological basis of a comprehensive grading system for the adverse effects of cancer treatment. , 2003, Seminars in radiation oncology.

[20]  L. V. van Kempen,et al.  Reactive oxygen species in melanoma and its therapeutic implications , 2007, Melanoma research.

[21]  O. Inanami,et al.  Ionizing radiation induces mitochondrial reactive oxygen species production accompanied by upregulation of mitochondrial electron transport chain function and mitochondrial content under control of the cell cycle checkpoint. , 2012, Free radical biology & medicine.

[22]  L. Dubois,et al.  [18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  Michael Scholz,et al.  Quantification of the relative biological effectiveness for ion beam radiotherapy: direct experimental comparison of proton and carbon ion beams and a novel approach for treatment planning. , 2010, International journal of radiation oncology, biology, physics.

[24]  Mary Helen Barcellos-Hoff,et al.  Radiation and the microenvironment – tumorigenesis and therapy , 2005, Nature Reviews Cancer.

[25]  T. Teshima,et al.  Carbon ion irradiation suppresses metastatic potential of human non-small cell lung cancer A549 cells through the phosphatidylinositol-3-kinase/Akt signaling pathway. , 2011, Journal of radiation research.

[26]  H. Yoshikawa,et al.  Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung , 1998, International journal of cancer.

[27]  U. Cortes,et al.  STAT3 is essential for the maintenance of neurosphere‐initiating tumor cells in patients with glioblastomas: A potential for targeted therapy? , 2011, International journal of cancer.

[28]  P. Scherle,et al.  Developing c-MET pathway inhibitors for cancer therapy: progress and challenges. , 2010, Trends in molecular medicine.

[29]  C. Hunter,et al.  Identifying Mechanisms for Therapeutic Intervention in Chordoma: c-Met Oncoprotein , 2008, Spine.

[30]  Zhigang Tian,et al.  Defining the critical hurdles in cancer immunotherapy , 2011, Journal of Translational Medicine.

[31]  Marco Durante,et al.  Assessing the risk of second malignancies after modern radiotherapy , 2011, Nature Reviews Cancer.

[32]  V. Zoete,et al.  Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition. , 2012, Journal of medicinal chemistry.

[33]  B. Nelson,et al.  Standard Treatments Induce Antigen-Specific Immune Responses in Prostate Cancer , 2007, Clinical Cancer Research.

[34]  B. Suarez-Alvarez,et al.  The NKG2D receptor: sensing stressed cells. , 2008, Trends in molecular medicine.

[35]  M. Mihm,et al.  CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS , 2008, Nature Clinical Practice Oncology.

[36]  S. Pestka,et al.  Chemotherapeutics and Radiation Stimulate MHC Class I Expression through Elevated Interferon-beta Signaling in Breast Cancer Cells , 2012, PloS one.

[37]  G. Fuller,et al.  Inhibition of p-STAT3 Enhances IFN-α Efficacy against Metastatic Melanoma in a Murine Model , 2010, Clinical Cancer Research.

[38]  Mark W. Dewhirst,et al.  Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response , 2008, Nature Reviews Cancer.

[39]  S. Morad,et al.  Ceramide-orchestrated signalling in cancer cells , 2012, Nature Reviews Cancer.

[40]  L. Bubendorf,et al.  High expression of indoleamine 2,3-dioxygenase gene in prostate cancer. , 2008, European journal of cancer.

[41]  Y. Bang,et al.  Phase II study of sunitinib as second-line treatment for advanced gastric cancer , 2010, Investigational New Drugs.

[42]  H. Shirato,et al.  Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy. , 2010, Cancer research.

[43]  M. Neuenhahn,et al.  NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβ , 2007, Cell.

[44]  J. S. Rao,et al.  Effects of irradiation on tumor cell survival, invasion and angiogenesis , 2010, Journal of Neuro-Oncology.

[45]  Weiping Zou,et al.  Immunosuppressive networks in the tumour environment and their therapeutic relevance , 2005, Nature Reviews Cancer.

[46]  S. Rafii,et al.  Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9–mediated progenitor cell mobilization , 2005, The Journal of experimental medicine.

[47]  R. Weichselbaum,et al.  Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. , 2009, Blood.

[48]  Y. Yonemitsu,et al.  Carbon‐ion beam treatment induces systemic antitumor immunity against murine squamous cell carcinoma , 2010, Cancer.

[49]  T. Nheu,et al.  Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling , 2005, Nature Medicine.

[50]  L. Coussens,et al.  The Tumor-Immune Microenvironment and Response to Radiation Therapy , 2010, Journal of Mammary Gland Biology and Neoplasia.

[51]  O. Witte,et al.  PET probes for distinct metabolic pathways have different cell specificities during immune responses in mice. , 2010, The Journal of clinical investigation.

[52]  G. Prendergast Immunological thought in the mainstream of cancer research , 2012, Oncoimmunology.

[53]  M. Kaag,et al.  Endothelial Membrane Remodeling Is Obligate for Anti-Angiogenic Radiosensitization during Tumor Radiosurgery , 2010, PloS one.

[54]  Y. Yamada,et al.  High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. , 2008, International journal of radiation oncology, biology, physics.

[55]  B. Pockaj,et al.  Cyclooxygenase-2 Inhibitor Enhances the Efficacy of a Breast Cancer Vaccine: Role of IDO1 , 2006, The Journal of Immunology.

[56]  Alberto Mantovani,et al.  Neutrophils in the activation and regulation of innate and adaptive immunity , 2011, Nature Reviews Immunology.

[57]  Abhishek D. Garg,et al.  Immunogenic cell death and DAMPs in cancer therapy , 2012, Nature Reviews Cancer.

[58]  Shuang Chen,et al.  Transforming Growth Factor-β Differentially Inhibits MyD88-dependent, but Not TRAM- and TRIF-dependent, Lipopolysaccharide-induced TLR4 Signaling* , 2005, Journal of Biological Chemistry.

[59]  J. Welsh,et al.  The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells , 2009, Radiation oncology.

[60]  G. Prendergast,et al.  Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway. , 2010, The American journal of pathology.

[61]  Ute Wirkner,et al.  Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-β receptor I kinase inhibitor LY2109761. , 2011, Neoplasia.

[62]  K. Hunter,et al.  Modeling metastasis in vivo. , 2004, Carcinogenesis.

[63]  T. Bortfeld IMRT: a review and preview , 2006, Physics in medicine and biology.

[64]  K. Tracey,et al.  HMGB1 as a cytokine and therapeutic target , 2002, Journal of endotoxin research.

[65]  C. Sautès-Fridman,et al.  The immune contexture in human tumours: impact on clinical outcome , 2012, Nature Reviews Cancer.

[66]  Michael Dougan,et al.  Immune therapy for cancer. , 2009, Annual review of immunology.

[67]  Eric Vivier,et al.  Targeting natural killer cells and natural killer T cells in cancer , 2012, Nature Reviews Immunology.

[68]  J. Castle,et al.  Exploiting the mutanome for tumor vaccination. , 2012, Cancer research.

[69]  D. Bigner,et al.  Glioblastoma multiforme: a review of where we have been and where we are going , 2009, Expert opinion on investigational drugs.

[70]  D. Roses,et al.  Prospective assessment of optimal individual position (prone versus supine) for breast radiotherapy: volumetric and dosimetric correlations in 100 patients. , 2012, International journal of radiation oncology, biology, physics.

[71]  K. Alitalo,et al.  VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. , 2011, Trends in molecular medicine.

[72]  A. Odermatt,et al.  Endoplasmic reticulum: reduced and oxidized glutathione revisited , 2013, Journal of Cell Science.

[73]  R. Steinman,et al.  Taking dendritic cells into medicine , 2007, Nature.

[74]  J. Routy,et al.  Human Activated T Lymphocytes Modulate IDO Expression in Tumors through Th1/Th2 Balance1 , 2009, The Journal of Immunology.

[75]  Liang Shen,et al.  The pharmacology of curcumin: is it the degradation products? , 2012, Trends in molecular medicine.

[76]  Lech Papiez,et al.  Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[77]  E. Proietti,et al.  Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy , 2012, Molecular oncology.

[78]  M. Bernstein,et al.  Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination? , 2009, Molecular bioSystems.

[79]  K. Yamaguchi,et al.  Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases. , 2009, Cancer research.

[80]  C. Daniel,et al.  Therapeutic opportunities for manipulating TReg cells in autoimmunity and cancer , 2012, Nature Reviews Drug Discovery.

[81]  S. Haeryfar,et al.  NKT cell costimulation: experimental progress and therapeutic promise. , 2011, Trends in molecular medicine.

[82]  M. Weller,et al.  Toll‐Like Receptor Engagement Enhances the Immunosuppressive Properties of Human Bone Marrow‐Derived Mesenchymal Stem Cells by Inducing Indoleamine‐2,3‐dioxygenase‐1 via Interferon‐β and Protein Kinase R , 2009, Stem cells.

[83]  J. Wolchok,et al.  The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activation. , 2008, The oncologist.

[84]  A. Evdokiou,et al.  Zoledronic acid protects against osteosarcoma‐induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model , 2010, International Journal of Cancer.

[85]  K. Rock,et al.  How dying cells alert the immune system to danger , 2008, Nature Reviews Immunology.

[86]  G. V. Vande Woude,et al.  Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer , 2009, Clinical Cancer Research.

[87]  S. Demaria,et al.  The convergence of radiation and immunogenic cell death signaling pathways , 2012, Front. Oncol..

[88]  Qiang Xu,et al.  Sensitization of human osteosarcoma cells to Vγ9Vδ2 T‐cell‐mediated cytotoxicity by zoledronate , 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[89]  E. Gore,et al.  Stereotactic radiosurgery for the management of brain metastases. , 2010, The New England journal of medicine.

[90]  Tak W. Mak,et al.  Cytochrome c: functions beyond respiration , 2008, Nature Reviews Molecular Cell Biology.

[91]  L. Zitvogel,et al.  How to improve the immunogenicity of chemotherapy and radiotherapy , 2011, Cancer and Metastasis Reviews.

[92]  E. Medico,et al.  Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. , 2011, Journal of the National Cancer Institute.

[93]  C. V. van Noesel,et al.  Radiation‐induced melanoma‐associated leucoderma, systemic antimelanoma immunity and disease‐free survival in a patient with advanced‐stage melanoma: a case report and immunological analysis , 2013, The British journal of dermatology.

[94]  T. Hei,et al.  Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival , 2008, Apoptosis.

[95]  H. Zhang,et al.  STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients. , 2013, The Journal of clinical investigation.

[96]  G. Dranoff,et al.  Combining immunotherapy and targeted therapies in cancer treatment , 2012, Nature Reviews Cancer.

[97]  A. Samii,et al.  Expression of hepatocyte growth factor and c‐MET in skull base chordoma , 2008, Cancer.

[98]  L. Zitvogel,et al.  Chemotherapy and radiotherapy: cryptic anticancer vaccines. , 2010, Seminars in immunology.

[99]  J. Pinilla-Ibarz,et al.  Enhanced CD8 T cell cross-presentation by macrophages with targeted disruption of STAT3. , 2010, Immunology letters.

[100]  A. Koong,et al.  Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. , 2010, International journal of radiation oncology, biology, physics.

[101]  T. Nakano,et al.  Application of carbon-ion beams or gamma-rays on primary tumors does not change the expression profiles of metastatic tumors in an in vivo murine model. , 2009, International journal of radiation oncology, biology, physics.

[102]  D. Jaffray Image-guided radiotherapy: from current concept to future perspectives , 2012, Nature Reviews Clinical Oncology.

[103]  L. Pfeffer,et al.  Curcumin Potentiates Rhabdomyosarcoma Radiosensitivity by Suppressing NF-κB Activity , 2013, PloS one.

[104]  Laurence Zitvogel,et al.  Immune parameters affecting the efficacy of chemotherapeutic regimens , 2011, Nature Reviews Clinical Oncology.

[105]  M. Pecaut,et al.  The impact of mouse strain on iron ion radio-immune response of leukocyte populations , 2010, International journal of radiation biology.

[106]  W. Hong,et al.  Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1alpha. , 2009, Cancer research.

[107]  M. Smyth,et al.  Improving cancer immunotherapy by targeting tumor-induced immune suppression , 2011, Cancer and Metastasis Reviews.

[108]  Hua Yu,et al.  STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.

[109]  Philippe Lambin,et al.  How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[110]  L. Marnett,et al.  COX-2 Inhibitors Modulate IL-12 Signaling Through JAK-STAT Pathway Leading to Th1 Response in Experimental Allergic Encephalomyelitis , 2006, Journal of Clinical Immunology.

[111]  A. Tefferi,et al.  Abscopal effect in a patient with melanoma. , 2012, New England Journal of Medicine.

[112]  S. Gerber,et al.  Radiation-Induced IFN-γ Production within the Tumor Microenvironment Influences Antitumor Immunity1 , 2008, The Journal of Immunology.

[113]  Kathryn D. Held,et al.  Effects of low fluences of radiations found in space on cellular systems , 2009, International journal of radiation biology.

[114]  E. Gragoudas,et al.  Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. , 2002, Archives of ophthalmology.

[115]  Edouard I Azzam,et al.  Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. , 2012, Cancer letters.

[116]  K. Foley,et al.  Phase I Evaluation of STA-1474, a Prodrug of the Novel HSP90 Inhibitor Ganetespib, in Dogs with Spontaneous Cancer , 2011, PloS one.

[117]  T. Padhya,et al.  HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment , 2010, The Journal of experimental medicine.

[118]  X. Pivot,et al.  Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells. , 2011, Cancer research.

[119]  G. Riggins,et al.  Molecular targeting of glioblastoma: Drug discovery and therapies. , 2011, Trends in molecular medicine.

[120]  C. Lawton Late outcomes following hypofractionated conformal radiotherapy vs. standard fractionation for localized prostate cancer: a nonrandomized contemporary comparison , 2010 .

[121]  M. Durante,et al.  Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation , 2012, Journal of radiation research.

[122]  C. Thiele,et al.  Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo , 2013, Oncotarget.

[123]  Marco Durante,et al.  Charged particles in radiation oncology , 2010, Nature Reviews Clinical Oncology.

[124]  D. Gabrilovich,et al.  Coordinated regulation of myeloid cells by tumours , 2012, Nature Reviews Immunology.

[125]  T R Mackie,et al.  History of tomotherapy , 2006, Physics in medicine and biology.

[126]  C Bert,et al.  Motion in radiotherapy: particle therapy , 2011, Physics in medicine and biology.

[127]  S. Demaria,et al.  Systemic effects of local radiotherapy. , 2009, The Lancet. Oncology.

[128]  Sunil Krishnan,et al.  Targeting inflammatory pathways for tumor radiosensitization. , 2010, Biochemical pharmacology.

[129]  M. Karamouzis,et al.  Targeting MET as a strategy to overcome crosstalk-related resistance to EGFR inhibitors. , 2009, The Lancet. Oncology.

[130]  M. van den Broek,et al.  Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation , 2012, The Journal of Immunology.

[131]  F. Marincola,et al.  Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma , 2011, Proceedings of the National Academy of Sciences.

[132]  A. Haimovitz-Friedman,et al.  Ceramide Biogenesis Is Required for Radiation-Induced Apoptosis in the Germ Line of C. elegans , 2008, Science.

[133]  H. Tsujii,et al.  Carbon ion radiotherapy for sacral chordoma. , 2011, The British journal of radiology.

[134]  Laurence Zitvogel,et al.  Immunogenic cell death in cancer therapy. , 2013, Annual review of immunology.

[135]  F. Hassan,et al.  Interleukin-10 inhibits tumor necrosis factor-α production in lipopolysaccharide-stimulated RAW 264.7 cells through reduced MyD88 expression , 2008, Innate immunity.

[136]  N. Halama,et al.  Seromic profiling of ovarian and pancreatic cancer , 2010, Proceedings of the National Academy of Sciences.

[137]  C. E. Alvarez,et al.  Dog models of naturally occurring cancer. , 2011, Trends in molecular medicine.

[138]  M. McCarty Minimizing the cancer-promotional activity of cox-2 as a central strategy in cancer prevention. , 2012, Medical hypotheses.

[139]  M. Todaro,et al.  Tumorigenic and metastatic activity of human thyroid cancer stem cells. , 2010, Cancer research.

[140]  J. Higgins,et al.  Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy , 2012, International journal of cancer.

[141]  Axel Hoos,et al.  Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria , 2009, Clinical Cancer Research.

[142]  M. Weller,et al.  Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12. , 2006, Brain : a journal of neurology.

[143]  A. Mantovani,et al.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.

[144]  J. Talmadge,et al.  Inflammatory cell infiltration of tumors: Jekyll or Hyde , 2007, Cancer and Metastasis Reviews.

[145]  N. Kawashima,et al.  Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[146]  F. Balkwill Tumour necrosis factor and cancer , 2009, Nature Reviews Cancer.

[147]  S. Ghosh,et al.  Mitochondria in innate immune responses , 2011, Nature Reviews Immunology.

[148]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[149]  K. Iwamoto,et al.  Local irradiation of murine melanoma affects the development of tumour‐specific immunity , 2009, Immunology.

[150]  R. Johnstone,et al.  Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies. , 2012, Cancer research.

[151]  John L. Meyer,et al.  The expanding roles of stereotactic body radiation therapy and oligofractionation: toward a new practice of radiotherapy. , 2011, Frontiers of radiation therapy and oncology.

[152]  S. Demaria,et al.  Combining radiotherapy and cancer immunotherapy: a paradigm shift. , 2013, Journal of the National Cancer Institute.

[153]  P. Vandenabeele,et al.  A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death , 2012, The EMBO journal.

[154]  A. Robles,et al.  HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair , 2008, Molecular Cancer Therapeutics.

[155]  Jian Jian Li,et al.  NF-κB-mediated adaptive resistance to ionizing radiation , 2008 .

[156]  R. Zlotecki,et al.  Response to sunitinib in combination with proton beam radiation in a patient with chondrosarcoma: a case report , 2012, Journal of Medical Case Reports.

[157]  Jedd D. Wolchok,et al.  Immunologic correlates of the abscopal effect in a patient with melanoma. , 2012, The New England journal of medicine.

[158]  L. Zitvogel,et al.  The secret ally: immunostimulation by anticancer drugs , 2012, Nature Reviews Drug Discovery.

[159]  K. Ohtomo,et al.  Enhancement of Antitumor Radiation Efficacy and Consistent Induction of the Abscopal Effect in Mice by ECI301, an Active Variant of Macrophage Inflammatory Protein-1α , 2008, Clinical Cancer Research.

[160]  James S Goydos,et al.  Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction , 2011, Cancer Immunology, Immunotherapy.

[161]  S. Gool,et al.  Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model , 2011, Cancer Immunology, Immunotherapy.

[162]  W. Lu,et al.  Synergistic antitumor effect of TRAIL in combination with sunitinib in vitro and in vivo. , 2010, Cancer letters.

[163]  R. Weichselbaum,et al.  Blockade of tumor necrosis factor alpha signaling in tumor-associated macrophages as a radiosensitizing strategy. , 2010, Cancer research.

[164]  Tadashi Kamada,et al.  A Review of Update Clinical Results of Carbon Ion Radiotherapy , 2012, Japanese journal of clinical oncology.

[165]  C. Mody,et al.  Immunotherapy in gliomas: limitations and potential of natural killer (NK) cell therapy. , 2011, Trends in molecular medicine.

[166]  J. Niederkorn Ocular Immune Privilege and Ocular Melanoma: Parallel Universes or Immunological Plagiarism? , 2012, Front. Immun..

[167]  P. Vandenabeele,et al.  ER stress-induced inflammation: does it aid or impede disease progression? , 2012, Trends in molecular medicine.

[168]  Kevin Camphausen,et al.  Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy , 2006 .

[169]  Paul Kremer,et al.  Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[170]  Toshikazu Nakamura,et al.  Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice , 2004, Cancer Gene Therapy.

[171]  S. Korreman Motion in radiotherapy: photon therapy , 2012, Physics in medicine and biology.

[172]  Marco Durante,et al.  Particle therapy for noncancer diseases. , 2012, Medical physics.

[173]  N. Kawashima,et al.  The Combination of Ionizing Radiation and Peripheral Vaccination Produces Long-term Survival of Mice Bearing Established Invasive GL261 Gliomas , 2006, Clinical Cancer Research.

[174]  S. Demaria,et al.  Radiation as an immunological adjuvant: current evidence on dose and fractionation , 2012, Front. Oncol..

[175]  Oliver Jäkel,et al.  Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial , 2010, BMC Cancer.

[176]  C. Melief Cancer immunotherapy by dendritic cells. , 2008, Immunity.

[177]  S. Demaria,et al.  Up-regulation of the Pro-inflammatory Chemokine CXCL16 is a Common Response of Tumor Cells to Ionizing Radiation , 2010, Radiation research.

[178]  Giuseppe Schettino,et al.  New insights on cell death from radiation exposure. , 2005, The Lancet. Oncology.

[179]  Simon C Watkins,et al.  Sunitinib facilitates the activation and recruitment of therapeutic anti‐tumor immunity in concert with specific vaccination , 2011, International journal of cancer.

[180]  Kou-Juey Wu,et al.  TWIST activation by hypoxia inducible factor-1 (HIF-1): Implications in metastasis and development , 2008, Cell cycle.

[181]  H. Moch,et al.  γ-Radiation Promotes Immunological Recognition of Cancer Cells through Increased Expression of Cancer-Testis Antigens In Vitro and In Vivo , 2011, PloS one.

[182]  P. Choong,et al.  Osteosarcoma treatment: state of the art , 2009, Cancer and Metastasis Reviews.

[183]  Sang-Gu Hwang,et al.  Bcl‐XL and STAT3 mediate malignant actions of γ‐irradiation in lung cancer cells , 2010, Cancer science.

[184]  J. Debus,et al.  Blockade of TGF-beta signaling by the TGF β RI kinase Inhibitor LY 2109761 enhances radiation response and prolongs survival in glioblastoma , 2011 .

[185]  E. Monti,et al.  Rhabdomyosarcomas: an overview on the experimental animal models , 2012, Journal of cellular and molecular medicine.

[186]  Roberto A. Maldonado,et al.  How tolerogenic dendritic cells induce regulatory T cells. , 2010, Advances in immunology.

[187]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[188]  Dirk Verellen,et al.  Innovations in image-guided radiotherapy , 2008, Nature Reviews Cancer.

[189]  C. Drake,et al.  Immunotherapy earns its spot in the ranks of cancer therapy , 2012, The Journal of experimental medicine.

[190]  Te Vuong,et al.  Past, present, and future of radiotherapy for the benefit of patients , 2013, Nature Reviews Clinical Oncology.

[191]  Zvi Fuks,et al.  Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis , 2003, Science.

[192]  Marco Durante,et al.  Charged particle therapy—optimization, challenges and future directions , 2013, Nature Reviews Clinical Oncology.

[193]  S. Demaria,et al.  Select forms of tumor cell apoptosis induce dendritic cell maturation , 2005, Journal of leukocyte biology.

[194]  G. Multhoff,et al.  Radiation-induced stress proteins - the role of heat shock proteins (HSP) in anti- tumor responses. , 2012, Current medicinal chemistry.

[195]  Hua Yu,et al.  Tumour immunology: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment , 2007, Nature Reviews Immunology.

[196]  Gerald McMahon,et al.  SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models. , 2003, Cancer research.

[197]  A. Bozec,et al.  Combination of sunitinib, cetuximab and irradiation in an orthotopic head and neck cancer model. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[198]  E. Smit,et al.  Design of clinical trials of radiation combined with antiangiogenic therapy. , 2007, The oncologist.

[199]  Tohru Okada,et al.  Carbon ion radiotherapy: clinical experiences at National Institute of Radiological Science (NIRS). , 2010, Journal of radiation research.

[200]  S. Demaria,et al.  Role of T lymphocytes in tumor response to radiotherapy , 2012, Front. Oncol..

[201]  N. Kawashima,et al.  Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. , 2004, International journal of radiation oncology, biology, physics.

[202]  P. van Endert,et al.  Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death , 2009, The EMBO journal.

[203]  R. Timmerman,et al.  The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology , 2011, Clinical & developmental immunology.

[204]  Joe Y. Chang,et al.  A Phase I Clinical Trial of Thoracic Radiotherapy and Concurrent Celecoxib for Patients with Unfavorable Performance Status Inoperable/Unresectable Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.

[205]  T. Hei,et al.  Suppression of the proinflammatory response of metastatic melanoma cells increases TRAIL‐induced apoptosis , 2011, Journal of cellular biochemistry.

[206]  S. Cullen,et al.  Granzymes in cancer and immunity , 2010, Cell Death and Differentiation.

[207]  K. Stagliano,et al.  Cutting Edge: Tumor-Specific CD8+ T Cells Infiltrating Prostatic Tumors Are Induced to Become Suppressor Cells1 , 2009, The Journal of Immunology.

[208]  J. Berzofsky,et al.  Transforming Growth Factor-β Production and Myeloid Cells Are an Effector Mechanism through Which CD1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor Immunosurveillance , 2003, The Journal of Experimental Medicine.

[209]  H. Nagawa,et al.  Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer , 2011, BMC Cancer.

[210]  L. Zitvogel,et al.  Abscopal but desirable , 2012, Oncoimmunology.

[211]  H. Matsui,et al.  TGF-β and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions , 2004, Oncogene.

[212]  Catrin Bauréus Koch,et al.  Radiation Immunomodulatory Gene Tumor Therapy of Rats with Intracerebral Glioma Tumors , 2010, Radiation research.